GH1 and acromegaly: lncH19 RNA presents itself as a novel biomarker of tumorigenesis, and since the papers focusing on GH-secreting adenomas are limited, the aim of the present study was to investigate whether lncH19 RNA expression could be useful in acromegaly patients.